Photoacoustic imaging for Ovarian Anomaly

Phase-Based Progress Estimates
Washington University School of Medicine, Saint Louis, MOOvarian AnomalyPhotoacoustic imaging - Device
What conditions do you have?

Study Summary

This trial is testing if a new imaging technique can reduce unnecessary surgeries without missing cancer. It's also testing if the technique can help find early ovarian cancer in high risk patients.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Through completion of surgery for all participants (estimated to be 5 years)

Year 5
Assess the impact of co-registered PAI/US on the potential reduction of benign surgeries as measured by the area under receiver characteristic curve (AUC)
Determine if co-registered PAI/US can be used as a sensitive and specific screening tool for early detection of malignant neoangiogenesis within a group of high-risk women
Determine normal changes of photoacoustic imaging parameters
Malignant Neoplasms

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Transvaginal photoacoustic imaging/ultrasound
1 of 1

Experimental Treatment

230 Total Participants · 1 Treatment Group

Primary Treatment: Photoacoustic imaging · No Placebo Group · N/A

Transvaginal photoacoustic imaging/ultrasoundExperimental Group · 2 Interventions: Photoacoustic imaging, Ultrasound · Intervention Types: Device, Device
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through completion of surgery for all participants (estimated to be 5 years)

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,162,938 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,822 Previous Clinical Trials
2,283,778 Total Patients Enrolled
Cary L Siegel, M.D.Principal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
40 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are 18 years or older and need to have one ovary removed as part of your surgery at Washington University School of Medicine.
You understand what the study involves and agree to participate in it.
Requirements to be included in the study's additional analysis.
You have a harmful mutation in one of the genes related to ovarian cancer, such as BRCA1, BRCA2, or others.
The requirements to be eligible to be measured for the main goals of the study.
You must be 18 years old or older.
You have a medical condition that requires surgery to remove at least one ovary, and you have been referred to Washington University School of Medicine for this surgery.
You are willing to be monitored for 1-2 years before deciding to have surgery to remove your ovaries as a preventive measure.

Frequently Asked Questions

What is the numerical representation of participants in this scientific study?

"Affirmative. According to, this experiment is presently searching for participants; the trial was initially published on February 9th 2020 and has been amended most recently on September 8th 2022. 230 individuals are needed from a single site." - Anonymous Online Contributor

Unverified Answer

Is this trial actively seeking out participants?

"According to the details archived on, this medical experiment is presently enrolling volunteers and has been ongoing since February 9th 2020 with its most recent amendment being made September 8th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.